Thu, 08th Oct 2020 11:06
BRUSSELS, Oct 8 (Reuters) - The European Commission said on
Thursday it had sealed a supply deal with Johnson & Johnson
for the supply of its potential COVID-19 vaccine for up
to 400 million people.
This is the third advance purchase contract signed by the EU
with makers of COVID-19 vaccines after deals with AstraZeneca
and Sanofi.
(Reporting by Francesco Guarascio; editing by Jason Neely
@fraguarascio)
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:
BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group s...
(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in Lond...
Focus on Fed minutes, Nvidia earnings *
(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the B...
Astrazeneca (AZN)